Hyderabad-based Hetero gets DCGI nod to manufacture, market Molnupiravir capsules
New Delhi: Hyderabad-based pharmaceuticals firm Hetero Tuesday said it has received permission from the Drug Controller General of India (DCGI) ...
Read moreNew Delhi: Hyderabad-based pharmaceuticals firm Hetero Tuesday said it has received permission from the Drug Controller General of India (DCGI) ...
Read moreHyderabad: Hetero, one of India's leading generic pharmaceutical companies and the world's largest producer of antiretroviral drugs, on Wednesday announced ...
Read moreNew Delhi: Four domestic pharma firms – Cipla, Jubilant Life Sciences, Hetero and Mylan – have entered into non-exclusive licensing agreements ...
Read more
I t may appear strange in most democracies, including India, that losing a no-confidence vote against a government leading to...
Read moreThe collapse of Bashar al-Assad’s regime in Syria is not an isolated event in the Middle East, but part of...
Read moreThe people of South Korea and their representatives showed the world last weekend how real democracy works. The country’s parliament...
Read moreIn 2021, I wrote a book called “Price of the Modi Years.” In one of its chapters, I compared India’s...
Read more